TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07403058: Endovascular Ablation Of The Right Greater Splanchnic Nerve In Subjects Having Heart Failure With Reduced Ejection Fraction: Randomized Controlled Feasibility Trial

Sponsor: Axon Therapies, Inc. · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 50 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$6,640,000

Rescue Site Savings

+$4,382,400

Unlock Full NCT07403058 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07403058 Rescue Dossier →